Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Svetlov SI et al. Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. 1999 Pediatr. Nephrol. pmid:10353406
Cruzado JM et al. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. 1999 May-Jun Exp. Nephrol. pmid:10352362
Rainsford KD Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. 1999 J. Pharm. Pharmacol. pmid:10344635
Mariano F et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 1999 Nephrol. Dial. Transplant. pmid:10344354
Cepinskas G et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. 1999 J. Cell. Sci. pmid:10341212
Nasu K et al. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. 1999 Mol. Hum. Reprod. pmid:10341002
McNulty CA et al. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10340944
Yoshimura T et al. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. 1999 Maturitas pmid:10340285
Aliberti JC et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. 1999 Infect. Immun. pmid:10338485
Alvi SA et al. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. 1999 Mol. Hum. Reprod. pmid:10338371
Markert R and Modzelewski B [Inflammatory mediators in the acute pancreatitis]. 1999 Pol. Merkur. Lekarski pmid:10337184
Huang YH et al. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. 1999 Clin. Exp. Immunol. pmid:10337026
Latorre E et al. Platelet-activating factor modulates brain sphingomyelin metabolism. 1999 Eur. J. Biochem. pmid:10336612
Rhee CK et al. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. 1999 Ann. Otol. Rhinol. Laryngol. pmid:10335705
Mori N et al. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. 1999 Am. J. Physiol. pmid:10330250
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
Rigat B et al. The GM2 activator protein, a novel inhibitor of platelet-activating factor. 1999 Biochem. Biophys. Res. Commun. pmid:10329374
Denizot Y et al. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? 1999 Cytokine pmid:10328869
Dong JC et al. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:10322836
Kavakli K et al. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. 1999 Thromb. Haemost. pmid:10235463
Jenks PJ et al. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects. 1999 Clin. Exp. Dermatol. pmid:10233666
Yamaguchi Y et al. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. 1999 Pancreas pmid:10231840
López-Novoa JM Potential role of platelet activating factor in acute renal failure. 1999 Kidney Int. pmid:10231429
Reinhardt JC et al. Immunofluorescent evidence of the platelet-activating factor receptor on human spermatozoa. 1999 Fertil. Steril. pmid:10231061
Hirashima Y et al. Deficient platelet-activating factor and related enzymes in hemimegalencephaly. 1999 Childs Nerv Syst pmid:10230665
Tool AT et al. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. 1999 Biochem. J. pmid:10229663
Han SJ et al. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. 1999 Eur. J. Immunol. pmid:10229101
Amroyan E et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. 1999 Phytomedicine pmid:10228608
Bastien Y et al. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. 1999 J. Immunol. pmid:10228030
Harrison KA et al. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). 1999 J Mass Spectrom pmid:10226361
Lee IS et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. 1999 Biol. Pharm. Bull. pmid:10220282
Hüseyinov A et al. Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection. 1999 Dig. Dis. Sci. pmid:10219821
Van de Weerdt ML et al. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves. 1999 Zentralbl Veterinarmed A pmid:10216447
Zardini DM and Tschirhart EJ [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. 1999 Jan-Feb Therapie pmid:10216433
Nagahata Y et al. Role of platelet activating factor on severity of ischemic colitis. 1999 Dis. Colon Rectum pmid:10211499
Wang X et al. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. 1999 Int. J. Pancreatol. pmid:10211421
Klettke U et al. Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells. 1999 Mar-Apr Allergy Asthma Proc pmid:10209689
Hasselwander O et al. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. 1999 Atherosclerosis pmid:10208487
Johnson CD Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. 1999 Dig Surg pmid:10207233
Brizzi MF et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 1999 Circ. Res. pmid:10205146
Held HD et al. Characterization of airway and vascular responses in murine lungs. 1999 Br. J. Pharmacol. pmid:10205008
Calcerrada MC et al. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. 1999 Biochem. Mol. Biol. Int. pmid:10204090
Wang X et al. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. 1999 Br J Surg pmid:10201790
Yamaguchi S et al. Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice. 1999 Life Sci. pmid:10201647
Park TS et al. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. 1999 J. Cereb. Blood Flow Metab. pmid:10197511
Lim H et al. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets. 1999 Biosci. Biotechnol. Biochem. pmid:10192909
Oh-hashi K et al. Dietary alpha-linolenate suppresses endotoxin-induced platelet-activating factor production in rat kidney. 1999 Lipids pmid:10188594
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. 1999 Stroke pmid:10187895
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. 1999 Stroke pmid:10187894
Kobayashi K et al. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region. 1999 Eur. J. Neurosci. pmid:10103126